INTRODUCTION
============

Cutaneous melanoma (CM) is a highly aggressive malignancy, originating from melanocytes, whose incidence is increasing worldwide, especially among the Caucasian population. ^[@r01]-[@r13]^ Australia and New Zealand have the highest incidence rates, with approximately 40-60 cases/100.000 inhabitants. ^[@r09],[@r14]^ In Brazil, according to the National Cancer Institute (INCA), estimated incidence rates for 2010 varied between 2.92-3.72/100.000 inhabitants, differing slightly between men and women. The highest incidence rates are found in the south of Brazil. ^[@r09],[@r10],[@r14]^

Brazil is a continentally large country with diverse ethnic characteristics, which vary depending on the region. ^[@r10],[@r15]^ Southern Brazil was largely colonized by European immigrants during the 19^th^ and 20^th^centuries ^[@r10]^. According to previous studies, Santa Catarina is the state with the highest melanoma rates in the country, followed by Rio Grande do Sul. ^[@r09],[@r15],[@r16]^

In a study carried out in the city of Blumenau - Santa Catarina, Brazil, Nasser found incidence rates of approximately 22.4/100.000 inhabitants, which are much higher than mean Brazilian figures.^[@r16]^ The area around Blumenau was largely colonized by European immigrants, especially Germans. The city of Brusque is located in southern Brazil, in the northwest of Santa Catarina, in the Itajai River Valley, approximately 40 kilometers from Blumenau. ^[@r17]^ According to the 2010 census from the Brazilian Institute of Geography and Statistics (IBGE), its population is 105.502,^[@r18]^ most of which is made up of Italian, German and Polish descendants.

We conducted this study in order to verify the clinical and epidemiological profile of melanoma patients in the city of Brusque. Further understanding of the epidemiological features of these patients may help to improve treatment of patients from this region and enhance precocious detection. To the best of our knowledge, this is the first study of its kind to be conducted in Brusque.

MATERIALS AND METHODS
=====================

We performed an observational descriptive retrospective study based on data collected from patients diagnosed with melanoma in Brusque - Santa Catarina - Brazil, between 1999 and 2013. One of the authors revised all the histopathological reports from January 1999 to February 2013. Clinical data were collected, including gender, age and localization of the primary lesion. Histopathological data, such as melanoma subtype, Breslow index and Clark index were also assessed.

Inclusion criteria were patients with CM diagnosed clinically and histopatologically during the period described above. Patients with extra-cutaneous primary disease were also included (1 case). Doubtful cases or cases in which some of the aforementioned data could not be assessed, were excluded from the study.

Data were analyzed using Epi Info V7 2013 software in order to compare the frequencies of the variables in each distribution, using the Goodness of Fit Chi-square test. We also estimated the frequency (proportions) with a 95% Confidence interval (CI). The results are summarized below.

RESULTS
=======

A total of 213 lesions were detected in 212 patients.

The majority of patients were females - 56.6%. Males represented 42.92% of the total amount of patients and in one case (0.4%), the gender was not specified. Females were statistically more frequently affected by melanoma, compared with males (p\< 0.05) - [Table 1](#t01){ref-type="table"}

###### 

Epidemiological profile and statistical analyses

  Characteristics             Patients   (%)                                         CI               (95%)     P
  --------------------------- ---------- ------------------------------------------- ---------------- --------- --------------
  **Sex**                                                                                                       
      Female                  120        (56.6%)                                     (49.93% -        63.28%)   **0.0459**
      Male                    91         (42.92%)                                    (36.26% -        49.59%)    
      Unclassified            1          (0.47%)                                     (0% -            1.39%)     
  **Localization**                                                                                              
      Head and neck           40         (18.87%)                                    (13.6% -         24.13%)   **0.0017**
      Upper Limbs             41         (19.34%)                                    (14.02% -        24.66%)    
      Lower Limbs             28         (13.21%)                                    (8.65% -         17.77%)    
      Trunk                   64         (30.19%)                                    (24.01% -        36.37%)    
      Mucosa                  2          (0.94%)                                     (0% -            2.24%)     
      Sigmoid                 1          (0.47%)                                     (0% -            1.39%)     
      Unknown                 36         (16.98%)                                    (11.93% -        22.04%)    
  **Age (years)**                                                                                               
      i ≤ 30                  24         (11.32%)                                    (7.06% -         15.59%)   **\< 0.001**
      31 ≤ i ≤ 50             74         (34.91%)                                    (28.49% -        41.32%)    
      i ≥ 51                  107        (50.47%)                                    (43.74% -        57.2%)     
      Unknown                 7          (3.3%)                                      (0.9% -          5.71%)     
  **Histological subtype**                                                                                      
      *\"IN SITU\"*           98         (46.01%)                                    (39.32% -        52.7%)    **\< 0.001**
      Nodular                 48         (22.54%)                                    (16.92% -        28.15%)    
      Superficial Spreading   41         (19.25%)                                    (13.95% -        24.54%)    
      Spitzoid                1          (0.47%)                                     (0% -            1.39%)     
      Fusocelular             1          (0.47%)                                     (0% -            1.39%)     
      Microinvasor            2          (0.94%)                                     (0% -            2.23%)     
      Acral                   1          (0.47%)                                     (0% -            1.39%)     
      Unclassified            21         (9.86%)                                     (5.86% -         13.86%)    
  **\"INVASIVE\"**            115        (53.99%)[\*](#TFN01){ref-type="table-fn"}   (47.3% -         60.68%)   **\< 0.001**
      *\"IN SITU\"*           98         (46.23%)                                    (39.52% -        52.94%)    
      ≤ 1 mm                  38         (17.92%)                                    (12.76% -        23.09%)    
      1.1 ≤ x ≤ 2 mm          25         (11.79%)                                    (7.45% -         16.13%)    
      2.1 ≤ x ≤ 3 mm          13         (6.13%)                                     (2.9% - 9.36%)             
      3.1 ≤ x ≤ 4 mm          12         (5.66%)                                     (2.55% -         8.77%)     
      4.1 ≤ x ≤5 mm           5          (2.36%)                                     (0.32% -         4.4%)      
      ≥ 5.1 mm                15         (7.08%)                                     (3.62% -         10.53%)    
      Unclassified            6          (2.83%)                                     (0.6% - 5.06%)             

I -- CI -- 95% confidence interval (estimated proportion) II -- P: P-value for chi-square test. If P \< 0.05 then there are significant differences between proportions within the distribution.

One of the invasive melanomas was located in the sigmoid and its Breslow index was not computed

Most patients were aged 51 or over (50.47%), followed by 31-50 years (34.91%). Only a few patients were under 30 (11.32%). These age range differences were statistically significant, as patients over 51 were more frequently affected by melanoma than the other age groups (p\< 0.05) - [Table 1](#t01){ref-type="table"}.

The trunk was the most common site of the primary lesion (30.19%), followed by the upper limbs (19.34%), head and neck (18.87%) and lower limbs (13.21%) - [Table 1](#t01){ref-type="table"}. Two patients presented with mucosal melanomas and one patient presented with a primary sigmoid melanoma. In approximately 17% of the cases, the site of the primary lesion was not specified. The trunk was the most commonly affected site and it was statistically significant (p\< 0.05).

The histopathological analysis revealed that most of the diagnosed lesions were invasive melanomas (54%) while in situ melanomas occurred in 46% of the cases. This difference was not statistically significant (P=0.2441). Among invasive melanomas, the most frequently found Breslow thicknesses were under 1mm and between 1-2mm. These two groups did not differ in terms of frequency but were more common than the others (p\< 0.05).

Nodular melanoma was found in 22.54% of the patients, followed by superficial spreading melanoma, present in 19.25%. Although the frequencies did not differ between these two histological types, they were more common in comparison to the others (p\<0.05).

DISCUSSION
==========

United States statistics reveal that 20% of the population will develop some form of skin cancer during their lifetime.^[@r02]^ MM is only the third most common skin cancer, alongside basocelular carcinoma and squamous cell carcinoma, but it is far more aggressive than the others.

Brazil is a country of continental dimensions with a complex ethnic background, exhibiting many differences. Hence, epidemiological studies conducted in the country show discrepant incidence rates and epidemiological characteristics, depending on the region in which they are performed.^[@r06],[@r08],[@r09],[@r11],[@r13],[@r14],[@r15],[@r16],[@r19]-[@r22]^ For instance, in the south and southwest of Brazil, melanoma patients are usually characterized as low phototype individuals (I-III) and the most commonly found histopathological subtype is superficial spreading melanoma. However, in the north of Brazil, a previous study reported that the predominant subtype is acral lentiginous melanoma and most patients are non-white.^[@r20]^ Further, there is a predominance of studies on the south of the country, while studies on the north and northeast are scarce.

For historical reasons, southern Brazil was colonized mostly by Europeans during several immigrant waves throughout the last 150 years, which is reflected in the fact that the population is composed mainly of fair-skinned individuals.^[@r09]^ Since these individuals are already known to be at high risk of CM development, it is expected that this region should have higher melanoma rates.^[@r23]^ The south of Brazil also has similar latitudes to Australia, the country with the highest melanoma rates in the world.

Many studies of CM in the Brazilian population have been conducted in the southern states. Numerous studies, including the present study, have been performed in Santa Catarina, showing similar histopathological and epidemiological features, but differing slightly as regards the predominant affected body site. ^[@r09],[@r15],[@r21],[@r22]^ Further, they do not all discuss the same stage of disease. Konrad et al. ^[@r22]^ detected mainly *in situ* melanomas, while Battisti et al. ^[@r21]^ discovered that most of their studied lesions were already invasive at the diagnosis. In the present study, there was no significant difference between invasive and non-invasive melanomas. Even among invasive melanomas, those with Breslow thicknesses under 2mm prevailed. Nevertheless, it is interesting to note that during the last four years (2009-2013), most of the lesions diagnosed were in situ melanomas (52% in situ as opposed to 48% invasive melanomas). This data may reflect the fact that, in recent years, there has been a rise in in situ melanoma detection, due mainly to more intensive screening and new technologies such as dermoscopy, digital dermoscopy and reflectance confocal microscopy. Precocious diagnosis is fundamental in melanoma patients care. Given the development of new medical devices that aid in early diagnosis, and since physicians as well as the general population are more aware of the disease\'s features, an increase in the detection of in situ melanomas might occur in the future. Although recently-launched drugs for metastatic melanoma have helped to increase survival rates among patients with advanced disease, early detection remains crucial in improving prognosis. ^[@r24],[@r25]^

In 2003, Gilles et al., representing the Brazilian Melanoma Group (GBM), published a consensus regarding pathology reports on cutaneous melanoma in Brazil.^[@r10],[@r26]^ Since then, efforts have been made to standardize pathological analyses in Brazil. As the present study began before the consensus, some lesions were not classified in accordance with it; nevertheless, in recent years, histopathological reports have taken the form suggested by the consensus.

Bakos et al. have outlined a model to detect patients at increased risk of melanoma. ^[@r27]^ Associated factors are light hair, eye and skin color, as well as freckles and sunburn. ^[@r07],[@r12]^ Previous papers have also demonstrated the effect of European ancestry on CM risk, finding a positive correlation. ^[@r06],[@r10],[@r23]^ Mutations in CDKN2A, CDK4 ^[@r27]^ and XPC ^[@r23]^ genes may be responsible for this additional risk. ^[@r27]^

Nasser conducted a large study in the city of Blumenau, revealing far higher melanoma incidence rates than those found in the Brazilian population in general.^[@r16]^ The population of the city of Brusque is geographically close and ethnically similar to that of Blumenau, so it is subjected to the same risk factors. In accordance with Nasser\'s study, ours also showed higher incidence rates in patients aged over 50, in addition to a predominance among females; and found that the trunk was the most affected site.

CONCLUSION
==========

This is an epidemiological study of the melanoma profile of patients in the city of Brusque. We found that melanomas were more frequent in females, in patients aged over 51, while the most commonly affected body site was the trunk. There was no difference between the superficial spreading and nodular melanoma subtypes, but they were more frequent than the others. Further, there was no statistically significant difference between invasive and in situ melanomas. Nevertheless, with respect to invasive melanomas, most had Breslow thicknesses of between under 1mm and 1-2mm.
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